(Q77163010)
Statements
Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (English)
P Gaynon
O Ek
T Zeren
L M Chelstrom
1 September 1998